Brodalumab mechanism of action in psoriasis
Answers
Answered by
0
Mechanism of action. Brodalumab binds to the interleukin-17 receptor and so prevents interleukin 17 (IL-17) from activating the receptor. (This mechanism is similar to that of another anti-psoriasis antibody, ixekizumab, which however binds to IL-17 itself.)
Answered by
0
Explanation:
Psoriasis is thought to be an immune system problem. Triggers include infections, stress and cold.
Similar questions